Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug.

Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug. ChemMedChem. 2012 Aug; 7(8):1361-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.